Sapient Capital LLC Novartis Ag Transaction History

Sapient Capital LLC

  • $4.93 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024
SELL
$95.27 - $108.47 $36,202 - $41,218
-380 Reduced 14.14%
2,308 $232 Million
Q4 2023

Feb 06, 2024
SELL
$92.27 - $101.54 $309,658 - $340,768
-3,356 Reduced 55.53%
2,688 $271 Million
Q4 2023

Jan 29, 2024
BUY
$92.27 - $101.54 $557,679 - $613,707
6,044 New
6,044 $610 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Sapient Capital LLC Portfolio

Follow Sapient Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sapient Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sapient Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email